MRS. Sheryl V Okuhara, D.O. is an internal medicine in Bradenton, FL. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. MRS. Sheryl V Okuhara, D.O. NPI is 1831116292. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
The provider's business location address is:
1854 RYE ROAD EAST
UNIT E
BRADENTON, FL
ZIP 34212
Phone: (941) 216-3939
Fax: (941) 782-3441
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Administration of influenza virus vaccine (HCPCS:G0008)
- Urinalysis, manual test (HCPCS:81002)
- Routine EKG using at least 12 leads including interpretation and report (HCPCS:93000)
- Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imple (HCPCS:G0180)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial im (HCPCS:G0179)
- Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
The enumeration date for this NPI number is 7/15/2006 and was last updated on 6/8/2018.